InvestSMART

CSL Limited (ASX: CSL) - Announcements

- Current share price for CSL : $196.080

ASX company news and announcements for CSL Limited (CSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CSL Limited (CSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CSL Limited (CSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CSL Limited (CSL)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$94,096 FY2015 Results Announcement and Analysts Presentation 12 Aug 2015 8:26AM $95.110 $196.080 risen by 106.16%
$94,096 Appendix 4E Directors Report and Financial Statements 12 Aug 2015 8:24AM $95.110 $196.080 risen by 106.16%
$94,096 Notice of Investor/Analyst Briefing - 2015 Full Year Result 11 Aug 2015 8:32AM $96.950 $196.080 risen by 102.25%
$94,096 Change to Company Details 6 Aug 2015 2:31PM $98.680 $196.080 risen by 98.70%
$94,096 Appendix 3B Amendment 5 Aug 2015 1:55PM $100.740 $196.080 risen by 94.64%
$94,096 Appendix 3B 4 Aug 2015 11:11AM $100.810 $196.080 risen by 94.50%
$94,096 Completes Novartis Influenza Vaccine Business Acquisition 3 Aug 2015 8:20AM $98.960 $196.080 risen by 98.14%
$94,096 Update on Novartis Influenza Vaccine Acquisition 31 Jul 2015 8:34AM $96.350 $196.080 risen by 103.51%
$94,096 US FDA Accepts for Review rFVIII BLA 28 Jul 2015 8:50AM $94.650 $196.080 risen by 107.16%
$94,096 Change to Company Details 21 Jul 2015 8:53AM $95.480 $196.080 risen by 105.36%
$94,096 Appendix 3B 14 Jul 2015 11:30AM $91.380 $196.080 risen by 114.58%
$94,096 Change to Company Details 26 Jun 2015 8:29AM $88.860 $196.080 risen by 120.66%
$94,096 Appendix 3B 23 Jun 2015 2:55PM $89.250 $196.080 risen by 119.70%
$94,096 CSL Behring to Present Pivotal Data 17 Jun 2015 8:27AM $88.200 $196.080 risen by 122.31%
$94,096 Final share buy-back notice - Appendix 3F 12 Jun 2015 8:34AM $89.020 $196.080 risen by 120.27%
$94,096 Daily share buy-back notice - Appendix 3E 12 Jun 2015 8:34AM $89.020 $196.080 risen by 120.27%
$94,096 Daily share buy-back notice - Appendix 3E 11 Jun 2015 8:32AM $89.170 $196.080 risen by 119.89%
$94,096 Daily share buy-back notice - Appendix 3E 10 Jun 2015 8:46AM $90.410 $196.080 risen by 116.88%
$94,096 Daily share buy-back notice - Appendix 3E 5 Jun 2015 8:28AM $90.080 $196.080 risen by 117.67%
$94,096 Changes to Company Details 5 Jun 2015 8:27AM $90.080 $196.080 risen by 117.67%
$94,096 Daily share buy-back notice - Appendix 3E 4 Jun 2015 9:36AM $91.500 $196.080 risen by 114.30%
$94,096 Appendix 3B 2 Jun 2015 2:19PM $93.530 $196.080 risen by 109.64%
$94,096 CSL Limited Financial Reporting Simplification 2 Jun 2015 10:14AM $93.340 $196.080 risen by 110.07%
$94,096 Daily share buy-back notice - Appendix 3E 29 May 2015 8:27AM $92.600 $196.080 risen by 111.75%
$94,096 Daily share buy-back notice - Appendix 3E 28 May 2015 8:34AM $92.420 $196.080 risen by 112.16%

1051 - 1075 of 1193 results

Page 43 of 48

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.